The percentage of participants who presented an improvement in fibrosis of 1 stage without worsening of MASH was 30% in the placebo group, 55% in the 5 mg tirzepatide group (difference versus placebo 25%
No significant correlation was found between metabolite levels and hyper/impulsive scores of ADHD, measures of core ASD symptoms (ADOS-2, SRS-P) or adaptive behavior (ABAS-2)
Understanding your peptide genetic profile helps select between semaglutide, tirzepatide, or dual-compound protocols before experiencing weeks of avoidable GI discomfort
Whether its a walk, a quick stretch, or light strength work, building those healthy habits now will help you stay strong, on and off the meds
Older research in Japan showed that TTFD supplementation could lead to a secondary B2 deficiency through increased urinary excretion
You may wish to discuss with your healthcare provider on other treatment options if you are at a healthy weight and do not wish to lose weight while on treatment
